PRESS RELEASE published on 01/31/2025 at 07:30, 2 months 15 days ago Informations privilégiées / Autres communiqués Poxel annonce les ventes et prévisions de TWYMEEG® au Japon, avec une croissance de 17% au T4 2024 et des ventes prévues à 7,9 milliards de yens pour 2024 Japon Ventes Prévisions Poxel TWYMEEG
BRIEF published on 01/20/2025 at 07:35, 2 months 26 days ago POXEL atteint des ventes majeures avec TWYMEEG® au Japon TWYMEEG® Poxel Sumitomo Pharma Redevances Ventes Japon
BRIEF published on 01/20/2025 at 07:35, 2 months 26 days ago POXEL Achieves Major Sales with TWYMEEG® in Japan Royalties TWYMEEG® Poxel Sumitomo Pharma Japan Sales
PRESS RELEASE published on 01/20/2025 at 07:30, 2 months 26 days ago Informations privilégiées / Autres communiqués Poxel annonce l'atteinte des 5 milliards de yens de ventes nettes de TWYMEEG® au Japon, entraînant des redevances croissantes et un paiement basé sur les ventes. Échéances de remboursement et perspective positive Japon Ventes Nettes Poxel TWYMEEG Redevances
PRESS RELEASE published on 01/20/2025 at 07:30, 2 months 26 days ago Inside Information / Other news releases Poxel to receive sales-based payment and higher royalties from Sumitomo Pharma in Q1 2025 for TWYMEEG® achieving JPY 5 billion net sales in Japan. Positive results expected beyond 2024 fiscal year Royalties Poxel Sumitomo Pharma TWYMEEG Sales-based Payment
BRIEF published on 12/23/2024 at 07:35, 3 months 23 days ago Poxel Releases Half-Year Financial Report for 2024 Financial Report 2024 Biopharmaceutical Poxel Audit Review
BRIEF published on 12/23/2024 at 07:35, 3 months 23 days ago Poxel publie son rapport financier semestriel pour 2024 Biopharmaceutique Rapport Financier 2024 Poxel Examen D'audit
PRESS RELEASE published on 12/23/2024 at 07:30, 3 months 23 days ago Half yearly financial reports and audit reports/limited reviews / Terms of availability of the half-yearly financial report Poxel SA announces availability of its 2024 half-year financial report, including condensed financial statements and activities for June 30, 2024 Biopharmaceutical Company Metabolic Disorders MASH 2024 Half-Year Financial Report Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 3 months 23 days ago Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise à disposition du rapport financier semestriel POXEL SA annonce la mise à disposition de son rapport financier semestriel au 30 juin 2024, incluant comptes consolidés, rapport d'activité et attestation Euronext Biopharmaceutique Maladies Métaboliques Rapport Financier Semestriel Poxel SA
PRESS RELEASE published on 12/23/2024 at 07:30, 3 months 23 days ago Rapports financiers et d'audit semestriels/examens réduits / Rapport financier semestriel
Published on 04/15/2025 at 23:40, 3 hours 45 minutes ago Electric Metals Announces Business Consulting Services Agreement With Terrella Capital
Published on 04/15/2025 at 23:30, 3 hours 55 minutes ago GameSquare Holdings Reports 2024 Full Year Results
Published on 04/15/2025 at 23:30, 3 hours 55 minutes ago AIML Announces Closing of Oversubscribed Private Placement
Published on 04/15/2025 at 23:00, 4 hours 25 minutes ago Cerrado Gold Announces Q1 2025 Production Results At Its Minera Don Nicolas Mine In Argentina
Published on 04/15/2025 at 23:54, 3 hours 31 minutes ago EQS-Adhoc: DATAGROUP enters into an Investment Agreement with and supports a public purchase offer of KKR at a price of EUR 54.00 per share in cash
Published on 04/15/2025 at 21:51, 5 hours 33 minutes ago EQS-Adhoc: Adtran Networks SE updates preliminary results for the financial year 2024
Published on 04/15/2025 at 18:53, 8 hours 31 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/15/2025 at 18:30, 8 hours 54 minutes ago GURIT REPORTS NET SALES OF CHF 85.2 MILLION IN THE FIRST QUARTER OF 2025; ANNUAL GENERAL MEETING APPROVES ALL AGENDA ITEMS
Published on 04/15/2025 at 18:00, 9 hours 25 minutes ago ALTHEORA: RESILIENCE DES RESULTATS ANNUELS 2024
Published on 04/15/2025 at 19:00, 8 hours 25 minutes ago Covivio Hotels - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 15 avril 2025
Published on 04/15/2025 at 18:00, 9 hours 25 minutes ago NFL Biosciences annonce la mise à disposition de son rapport financier annuel 2024
Published on 04/15/2025 at 18:00, 9 hours 25 minutes ago Covivio Hotels - Revenus à fin mars 2025 : la croissance se poursuit
Published on 04/15/2025 at 18:00, 9 hours 25 minutes ago Covivio Hotels - Revenues at end-March 2025: continued growth
Published on 04/15/2025 at 17:45, 9 hours 40 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 mars 2025
